Effects of clindamycin and amoxycillin as prophylaxis against early implant failure: double-blinded randomized clinical trial.

Autor: Pradillo-Gallego D; Master of Oral Surgery and Implant Dentistry, School of Dentistry, University of Granada, Granada, Spain., Manzano-Moreno FJ; Master of Oral Surgery and Implant Dentistry, School of Dentistry, University of Granada, Granada, Spain. fjmanza@ugr.es.; Department of Stomatology, School of Dentistry, University of Granada, Colegio Máximo s/n, Granada, 18071, Spain. fjmanza@ugr.es.; Biomedical Group (BIO277), University of Granada, Granada, Spain. fjmanza@ugr.es.; Instituto Investigación Biosanitaria, ibs.Granada, Granada, Spain. fjmanza@ugr.es., Ocaña-Peinado FM; Department of Statistics and Operations Research, University of Granada, Granada, Spain., Olmedo-Gaya MV; Master of Oral Surgery and Implant Dentistry, School of Dentistry, University of Granada, Granada, Spain.; Department of Stomatology, School of Dentistry, University of Granada, Colegio Máximo s/n, Granada, 18071, Spain.

Publikováno v: Clinical oral investigations [Clin Oral Investig] 2024 Nov 16; Vol. 28 (12), pp. 643. Date of Electronic Publication: 2024 Nov 16.

Does Adjunctive Clindamycin Have a Role in Staphylococcus aureus Bacteremia? A Protocol for the Adjunctive Treatment Domain of the Staphylococcus aureus Network Adaptive Platform (SNAP) Randomized Controlled Trial.

Autor: Anpalagan K; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia.; School of Medicine, University of Western Australia, Perth, Western Australia, Australia., Dotel R; Department of Infectious Diseases, Blacktown Hospital, Westmead, New South Wales, Australia.; Centre for Infectious Diseases and Microbiology, Westmead Hospital, Westmead, New South Wales, Australia., MacFadden DR; Faculty of Medicine, University of Ottawa, Canada, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Smith S; Department of Infectious Disease, Cairns Hospital, Cairns, Queensland, Australia., Voss L; Starship's Children Health, Te Toka Tumai Auckland, New Zealand., Petersiel N; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Marks M; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.; Hospital for Tropical Diseases, University College London Hospital, London, United Kingdom.; Division of Infection and Immunity, University College London, London, United Kingdom., Marsh J; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia., Mahar RK; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria, Australia.; Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Parkville, Victoria, Australia., McGlothlin A; Berry Consultants, Austin, Texas, USA., Lee TC; Clinical Practice Assessment Unit and Division of Infectious Diseases, McGill University, Montreal, Quebec, Canada., Goodman A; Medical Research Council Clinical Trials Unit, Department of Infectious Diseases, University College London, Guy's and St Thomas' Foundation NHS Trust, London, United Kingdom., Morpeth S; Middlemore Hospital, Auckland, New Zealand., Davis JS; Global and Tropical Health, Menzies School of Health Research, Darwin, Northern Territory, Australia.; The Immunology and Infectious Diseases Unit, John Hunter Hospital, University of Newcastle, Newcastle, New South Wales, Australia.; School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia., Tong SYC; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Bowen AC; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia.; School of Medicine, University of Western Australia, Perth, Western Australia, Australia.; Global and Tropical Health, Menzies School of Health Research, Darwin, Northern Territory, Australia.; Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Sep 26; Vol. 79 (3), pp. 626-634.

Mechanistic Basis for the Translation Inhibition of Cutibacterium acnes by Clindamycin.

Autor: Lomakin IB; Department of Dermatology, Yale University, New Haven, Connecticut, USA. Electronic address: ivan.lomakin@yale.edu., Devarkar SC; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA., Grada A; Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Bunick CG; Department of Dermatology, Yale University, New Haven, Connecticut, USA; Program in Translational Biomedicine, Yale University School of Medicine, New Haven, Connecticut, USA. Electronic address: christopher.bunick@yale.edu.

Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2024 Nov; Vol. 144 (11), pp. 2553-2561.e3. Date of Electronic Publication: 2024 Aug 08.

Gentamicin and clindamycin antibiotic-eluting depot technology eradicates S. aureus in an implant-associated osteomyelitis pig model without systemic antibiotics.

Autor: Henriksen NL; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Serrano-Chávez E; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Fuglsang-Madsen A; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Jensen LK; Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark., Gottlieb H; Department of Orthopedic Surgery, Herlev Hospital, Herlev, Denmark., Bue M; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus, Denmark., Andresen TL; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Henriksen JR; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark., Hansen AE; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Oct 08; Vol. 68 (10), pp. e0069124. Date of Electronic Publication: 2024 Sep 17.

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Male and Female Acne: Phase 3 Analysis.

Autor: Lain ET, Bhatia N, Kircik L, Gold LS, Harper JC, Bunick CG, Guenin E, Baldwin H, Feldman SR, Rosso JQD

Publikováno v: Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2024 Oct 01; Vol. 23 (10), pp. 873-881.